Author:
Zhao Shuang,Zhang Shuman,Zhang Weiwei,Gao Yi,Rong Chengbo,Wang Hexiang,Liu Yu,Wong Jack Ho,Ng Tzibun
Abstract
Abstract
Fatty liver (FLD) disease is a consequence of metabolic syndrome, which is a health problem worldwide with a phenomenal rise in prevalence. In this study, two hepatoprotective polysaccharide-peptides were extracted from the mushroom Auricularia polytricha followed by chromatographic fractionation of the extract on the ion exchanger DEAE-cellulose and gel filtration on Sephadex-200 to yield two purified fractions: APPI and APPII. The monosaccharide compositions, FT-IR, N-terminal sequences, internal peptide sequences and molecular weights of the two fractions were determined. Furthermore, their hepatoprotective effect on human hepatoma HepG2 cells in vitro and in an animal model of fatty liver disease was evidenced by the findings that APPI and APPII diminished lipid deposit in cells, blood and the liver, increased cellular antioxidant activity and viability, and protected the liver against injury. The mechanistic study revealed that APPI and APPII activated the adiponectin pathway, up-regulated expression of genes controlling free fatty acid (FFA) oxidation, such as AMPK, CPTl, ACOX1 and PPARα genes, enhanced lipid metabolism, preserved hepatic function, promoted the antioxidant defense system and reduced lipid peroxidation. Hence the bioactive compounds of A. polytricha could serve as therapeutic agents in the food and pharmaceutical industries.
Funder
Beijing Academy of Agricultural and Forestry Sciences
Publisher
Springer Science and Business Media LLC
Reference92 articles.
1. Yang, Z. et al. Protective effect of Anoectochilus roxburghii polysaccharide against CCl4-induced oxidative liver damage in mice. Int. J. Biol. 96, 442–450 (2017).
2. Wang, X. Y., Luo, J. P., Chen, R., Zha, X. Q. & Pan, L. H. Dendrobium huoshanense polysaccharide prevents ethanol-induced liver injury in mice by metabolomic analysis. Int. J. Biol. 78, 354–362 (2015).
3. Yin, Y. et al. Luteolin improves non-alcoholic fatty liver disease in db/db mice by inhibition of liver X receptor activation to down-regulate expression of sterol regulatory element binding protein 1c. Biochem. Biophys. Res. Commun. 482, 720–726 (2017).
4. Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American gastroenterological association, american association for the study of liver diseases, and American College of Gastroenterology. Gastroenterology 142, 1592–1609 (2012).
5. Doulberis, M., Kotronis, G., Gialamprinou, D., Kountouras, J. & Katsinelos, P. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism 71, 182–197 (2017).
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献